Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption
Description
The present notice does not concern the award of a public contract within the meaning of the Public Procurement Directive (2014/24/EU) or the cartel procurement law. In the interest of providing as broad information as possible to interested pharmaceutical enterprises, this notice is published in the Supplement to the Official Journal of the European Union. The procedure designation "Open Procedure" (Section IV.1.1) used in the present notice text is due to the requirements of the notice form. Neither the use of this designation nor the use of the medium "TED" implies any submission to procurement regulations whose applicability is not compulsorily prescribed by law or procurement regulations. This is a framework agreement with an option to join, relating to various active substances.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Miscellaneous medical devices and products – VE 473.05 105 Deckenversorgungseinheiten Medien
Universitätsklinikum HeidelbergGermanyMiscellaneous medical devices and productsInstallation services of medical equipmentDeadline in 29 daysPublished on Nov 19, 2026
Germany – Medical equipments, pharmaceuticals and personal care products – Absaugung, Invasive Blutdruckmessung und Regionalanästhesie
EK-UNICO GmbHGermanyMedical equipments, pharmaceuticals and personal care productsVenepuncture, blood sampling devicesAnaesthesia and resuscitationDeadline in 32 daysPublished on Nov 19, 2026
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Aflibercept, ausgenommen 114,3 mg/ml (ATC-Code: S01LA05).
AOK Niedersachsen. Die Gesundheitskasse.GermanyPharmaceutical productsDeadline in 707 daysPublished on Nov 19, 2026
Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption
BARMER Beschaffung und VergabeGermanyPharmaceutical productsDeadline in 438 daysPublished on Nov 19, 2026